# Weyco Group Inc: overview WEYS · Nasdaq · CIK 106532 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/weys.md) · [Financials](/companies/weys/financials.md) · [Filings](/companies/weys/filings.md) · [Insiders](/companies/weys/insiders.md) Latest reported revenue: [$62.2m](/filings/0001104659-26-092615.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 7, 2026 (XBRL us-gaap:Revenues, accession 0001104659-26-092615). ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [74.3](/filings/0001104659-25-108344.md) | [80.5 d](/filings/0001104659-26-027690.md) | [68.0](/filings/0001104659-26-057266.md) | [58.2](/filings/0001104659-26-092615.md) | [73.1](/filings/0001104659-25-108344.md) | [76.8 d](/filings/0001104659-26-027690.md) | [68.0](/filings/0001104659-26-057266.md) | [62.2](/filings/0001104659-26-092615.md) | | Gross margin | % | [44.3%](/filings/0001104659-25-108344.md) | [47.9% d](/filings/0001104659-26-027690.md) | [44.6%](/filings/0001104659-26-057266.md) | [43.3%](/filings/0001104659-26-092615.md) | [40.7%](/filings/0001104659-25-108344.md) | [44.1% d](/filings/0001104659-26-027690.md) | [44.2%](/filings/0001104659-26-057266.md) | [70.4%](/filings/0001104659-26-092615.md) | | Operating margin | % | [13.7%](/filings/0001104659-25-108344.md) | [14.3% d](/filings/0001104659-26-027690.md) | [10.3%](/filings/0001104659-26-057266.md) | [6.7%](/filings/0001104659-26-092615.md) | [11.0%](/filings/0001104659-25-108344.md) | [13.3% d](/filings/0001104659-26-027690.md) | [11.0%](/filings/0001104659-26-057266.md) | [27.4%](/filings/0001104659-26-092615.md) | | Net margin | % | [10.8%](/filings/0001104659-25-108344.md) | [12.4% d](/filings/0001104659-26-027690.md) | [8.1%](/filings/0001104659-26-057266.md) | [3.9%](/filings/0001104659-26-092615.md) | [9.0%](/filings/0001104659-25-108344.md) | [11.3% d](/filings/0001104659-26-027690.md) | [9.0%](/filings/0001104659-26-057266.md) | [21.4%](/filings/0001104659-26-092615.md) | | Diluted EPS | $ per share | [0.84](/filings/0001104659-25-108344.md) | not reported | [0.57](/filings/0001104659-26-057266.md) | [0.24](/filings/0001104659-26-092615.md) | [0.69](/filings/0001104659-25-108344.md) | not reported | [0.64](/filings/0001104659-26-057266.md) | [1.39](/filings/0001104659-26-092615.md) | | Free cash flow | $m | [(0.9) d](/filings/0001104659-25-108344.md) | [19.9 d](/filings/0001104659-26-027690.md) | [3.7](/filings/0001104659-26-057266.md) | [10.0 d](/filings/0001104659-26-092615.md) | [(1.3) d](/filings/0001104659-25-108344.md) | [23.1 d](/filings/0001104659-26-027690.md) | [16.9](/filings/0001104659-26-057266.md) | [6.8 d](/filings/0001104659-26-092615.md) | - Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [268](/filings/0001410578-23-000248.md) | [352](/filings/0001558370-24-003196.md) | [318](/filings/0001558370-25-002984.md) | [290](/filings/0001104659-26-027690.md) | [276](/filings/0001104659-26-027690.md) | | Gross margin | % | [40.1%](/filings/0001410578-23-000248.md) | [41.1%](/filings/0001558370-24-003196.md) | [44.9%](/filings/0001558370-25-002984.md) | [45.3%](/filings/0001104659-26-027690.md) | [43.2%](/filings/0001104659-26-027690.md) | | Operating margin | % | [9.6%](/filings/0001410578-23-000248.md) | [11.5%](/filings/0001558370-24-003196.md) | [12.9%](/filings/0001558370-25-002984.md) | [12.6%](/filings/0001104659-26-027690.md) | [10.6%](/filings/0001104659-26-027690.md) | | Net margin | % | [7.7%](/filings/0001410578-23-000248.md) | [8.4%](/filings/0001558370-24-003196.md) | [9.5%](/filings/0001558370-25-002984.md) | [10.4%](/filings/0001104659-26-027690.md) | [8.4%](/filings/0001104659-26-027690.md) | | Diluted EPS | $ per share | [2.12](/filings/0001410578-23-000248.md) | [3.07](/filings/0001558370-24-003196.md) | [3.17](/filings/0001558370-25-002984.md) | [3.16](/filings/0001104659-26-027690.md) | [2.41](/filings/0001104659-26-027690.md) | | Free cash flow | $m | [5.4](/filings/0001410578-23-000248.md) | [(32.2)](/filings/0001558370-24-003196.md) | [95.3](/filings/0001558370-25-002984.md) | [36.3](/filings/0001104659-26-027690.md) | [35.5](/filings/0001104659-26-027690.md) | - Revenue. XBRL Revenue: us-gaap:Revenues. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/weys/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $23.5m | 596,245 | | Added +7,464 | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $18.2m | 463,128 | | Added +20,675 | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $10.2m | 258,103 | | Reduced −20,067 | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $6.4m | 163,369 | | Added +7,595 | | [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $4.2m | 105,986 | | Reduced −1,276 | | [BRIDGEWAY CAPITAL MANAGEMENT, LLC](/funds/1107261.md) | 2026-06-30 | $4.1m | 103,093 | | Unchanged | | [Bank of New York Mellon Corp](/funds/1390777.md) | 2026-06-30 | $3.0m | 75,058 | | Added +984 | | [North Star Investment Management Corp.](/funds/1342857.md) | 2026-06-30 | $2.3m | 59,325 | | Unchanged | | [NORTHERN TRUST CORP](/funds/73124.md) | 2026-06-30 | $2.2m | 57,181 | | Added +1,953 | | [Empowered Funds, LLC](/funds/1592828.md) | 2026-06-30 | $2.1m | 53,793 | | Unchanged | ## Recent filings [All 1,240 filings](/companies/weys/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-09-24 | 19:59 ET | [8-K](/filings/0001104659-26-110380.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001104659-26-110380 | | 2026-08-07 | 18:34 ET | [10-Q](/filings/0001104659-26-092615.md) | Quarterly report, period 2026-06-30 | 0001104659-26-092615 | | 2026-08-04 | 20:05 ET | [8-K](/filings/0001104659-26-090357.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-090357 | | 2026-06-24 | 17:09 ET | [8-K](/filings/0001104659-26-077207.md) | 1.02 Termination of a material agreement | 0001104659-26-077207 | | 2026-05-07 | 21:04 ET | [10-Q](/filings/0001104659-26-057266.md) | Quarterly report, period 2026-03-31 | 0001104659-26-057266 | | 2026-05-07 | 19:38 ET | [8-K](/filings/0001104659-26-057042.md) | 5.07 Shareholder vote results | 0001104659-26-057042 | | 2026-05-05 | 20:05 ET | [8-K](/filings/0001104659-26-055618.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-055618 | | 2026-04-02 | 17:50 ET | [DEF 14A](/filings/0001104659-26-039031.md) | Proxy statement, period 2026-05-05 | 0001104659-26-039031 | | 2026-03-13 | 20:22 ET | [10-K](/filings/0001104659-26-027690.md) | Annual report, period 2025-12-31 | 0001104659-26-027690 | | 2026-03-03 | 21:06 ET | [8-K](/filings/0001104659-26-022833.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-022833 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001104659-26-027690.md), filed Mar 13, 2026. ## Forecast league Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/afdff353-5c5f-47fc-a808-3977234246ee) ## About the filer - CIK: 106532 - Tickers: WEYS - Exchange: Nasdaq - SIC code: 5130 Wholesale-Apparel, Piece Goods & Notions - State of incorporation: WI - Filer category: Accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:21 ET. No prices; not investment advice.